Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7Breast Neoplasms 7Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myeloid, Acute 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia 5Congenital Abnormalities 5Carcinoma, Ovarian Epithelial 5Waldenstrom Macroglobulinemia 4Lymphoma, Large-Cell, Immunoblastic 4Burkitt Lymphoma 4Myelodysplastic Syndromes 3Melanoma 3Lung Neoplasms 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Accelerated Phase 3Carcinoma, Non-Small-Cell Lung 3Blast Crisis 3Wilms Tumor 2Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Testicular Neoplasms 2Stomach Neoplasms 2Sezary Syndrome 2Recurrence 2Prostatic Neoplasms 2

Interventions

Cytarabine 23Mitoxantrone 9Etoposide 8Idarubicin 5Filgrastim 5tipifarnib 4fludarabine phosphate 4Daunorubicin 4Cyclophosphamide 4Topotecan 3Sorafenib 3Clofarabine 3Bortezomib 3Azacitidine 3tanespimycin 2alvocidib 2Peripheral Blood Stem Cell Transplantation 2Imatinib Mesylate 2Granulocyte Colony-Stimulating Factor 2Everolimus 2Cladribine 2Carboplatin 2Busulfan 2Arsenic Trioxide 2venetoclax 1veliparib 1trebananib 1sargramostim 1romiplostim 1romidepsin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Monocytic, Acute × Flow Cytometry × Clear all
NCT01127009 2015-08-13

Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia

Case Comprehensive Cancer Center

Phase 1 Completed
3 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡